INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $35,000 | +40.0% | 13,000 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $25,000 | -7.4% | 13,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $27,000 | +3.8% | 13,000 | 0.0% | 0.01% | -10.0% |
| Q4 2017 | $26,000 | +52.9% | 13,000 | 0.0% | 0.01% | +42.9% |
| Q3 2017 | $17,000 | -15.0% | 13,000 | 0.0% | 0.01% | -22.2% |
| Q2 2017 | $20,000 | -52.4% | 13,000 | 0.0% | 0.01% | -57.1% |
| Q1 2017 | $42,000 | – | 13,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |